Time to Protection and Adherence Requirements of Raltegravir With or Without Lamivudine in Protection From HIV Infection

NCT03205566 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Hiv

Interventions

DRUG: Raltegravir 400Mg Tab
DRUG: Lamivudine 150Mg Tablet

Sponsor

Guy's and St Thomas' NHS Foundation Trust